228 related articles for article (PubMed ID: 22608344)
1. Intravenous thrombolysis in a stroke patient taking dabigatran.
Lee VH; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
[TBL] [Abstract][Full Text] [Related]
2. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
3. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
4. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis in a stroke patient taking dabigatran.
Testai FD
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22868184
[No Abstract] [Full Text] [Related]
6. Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke.
Bugnicourt JM; Duru C; Picard C; Godefroy O
Clin Ther; 2008 Sep; 30(9):1675-80. PubMed ID: 18840373
[TBL] [Abstract][Full Text] [Related]
7. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
[TBL] [Abstract][Full Text] [Related]
8. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
[TBL] [Abstract][Full Text] [Related]
10. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
Baruch L; Sherman O
Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
Marrone LC; Marrone AC
Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
[No Abstract] [Full Text] [Related]
12. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
[TBL] [Abstract][Full Text] [Related]
13. Three cases of middle cerebral artery occlusion emergently revascularized with a balloon-expandable coronary bare stent after intravenous tissue plasminogen activator.
Fukuoka T; Dembo T; Nagoya H; Deguchi I; Maruyama H; Kanazawa R; Kohyama S; Yamane F; Ishihara S; Tanahashi N
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):883-9. PubMed ID: 21767964
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
[TBL] [Abstract][Full Text] [Related]
15. Response to the letter by Lee et al.
Lee V; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22902145
[No Abstract] [Full Text] [Related]
16. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
[No Abstract] [Full Text] [Related]
17. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
[TBL] [Abstract][Full Text] [Related]
18. [Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment-a case report and review of literature].
Inaishi J; Nogawa S; Mano Y; Yoshizaki T; Okada S
Rinsho Shinkeigaku; 2014; 54(3):238-40. PubMed ID: 24705841
[TBL] [Abstract][Full Text] [Related]
19. Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
Müller P; Topakian R; Sonnberger M; Nußbaumer K; Windpessl M; Eder V; Nesser HJ; Trenkler J; Haring HP
Clin Neurol Neurosurg; 2013 Oct; 115(10):2257-9. PubMed ID: 23921437
[No Abstract] [Full Text] [Related]
20. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
